{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:38:52Z","timestamp":1775756332980,"version":"3.50.1"},"reference-count":31,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1253\/circj.cj-08-0560","type":"journal-article","created":{"date-parts":[[2008,12,25]],"date-time":"2008-12-25T05:55:49Z","timestamp":1230184549000},"page":"145-151","source":"Crossref","is-referenced-by-count":31,"title":["Efficacy of Abciximab for Patients Undergoing Balloon Angioplasty Data From Japanese Evaluation of c7E3 Fab for Elective and Primary PCI Organization in Randomized Trial (JEPPORT)"],"prefix":"10.1253","volume":"73","author":[{"given":"Yoshihisa","family":"Nakagawa","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tenri Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakiyo","family":"Nobuyoshi","sequence":"additional","affiliation":[{"name":"Kokura Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsu","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Toranomon Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiichiro","family":"Meguro","sequence":"additional","affiliation":[{"name":"Sendai Kousei Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyoshi","family":"Yokoi","sequence":"additional","affiliation":[{"name":"Kokura Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saichi","family":"Hosoda","sequence":"additional","affiliation":[{"name":"Sakakibara Heart Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuo","family":"Kanmatsuse","sequence":"additional","affiliation":[{"name":"Nihon University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Matsumori","sequence":"additional","affiliation":[{"name":"Kyoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigetake","family":"Sasayama","sequence":"additional","affiliation":[{"name":"Doshisha University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ellis SG, Roubin GS, King SB III, Douglas JS, Weintraub WS, Thomas RG, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988; 77: 372-379.","DOI":"10.1161\/01.CIR.77.2.372"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Detre KM, Holmes DR, Holubkov R, Cowley MJ, Bourassa MG, Faxon DP, et al. Incidence and consequences of periprocedural occlusion: The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1990; 82: 739-750.","DOI":"10.1161\/01.CIR.82.3.739"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(07)80005-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ. Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992; 19: 926-935.","DOI":"10.1016\/0735-1097(92)90272-O"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199346010-00003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988; 12: 616-623.","DOI":"10.1016\/S0735-1097(88)80046-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, De Feyter PJ, van den Brand M, et al. Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon: A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988; 77: 361-371.","DOI":"10.1161\/01.CIR.77.2.361"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-961.","DOI":"10.1056\/NEJM199404073301402"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. The EPILOG Investigators. Platelet glycoprotein IIb\/IIIa receptor blockage and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336: 1689-1696.","DOI":"10.1056\/NEJM199706123362401"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10452-9"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)85010-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Smith SC, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, et al. ACC\/AHA Guidelines for percutaneous coronary intervention (Revision of the 1993 PTCA Guidelines). J Am Coll Cardiol 2001; 37: 2215-2239.","DOI":"10.1016\/S0735-1097(01)01344-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC\/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology\/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2000; 102: 1193-1209.","DOI":"10.1161\/01.CIR.102.10.1193"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. N Engl J Med 1985; 312: 932-936.","DOI":"10.1056\/NEJM198504043121437"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Rao AK, Pratt C, Berke A, Jaffe A, Ockene I, Schreiber TL, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial. Phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988; 11: 1-11.","DOI":"10.1016\/0735-1097(88)90158-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kastrati A, Mehilli J, Neumann FJ, Dotzer F, ten Berg J, Bollwein H, et al. Intracoronary stenting and antithrombotic: Regimen Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators. JAMA 2006; 295: 1531-1538.","DOI":"10.1001\/jama.295.13.joc60034"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106213442503"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07442-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Roffia M, Chewa DP, Mukherjeea D, Bhatta DL, Whitea JA, Moliternoa DJ, et al. Platelet glycoprotein IIb\/IIIa inhibition in acute coronary syndromes: Gradient of benefit related to the revascularization strategy. Eur Heart J 2002; 23: 1441-1448.","DOI":"10.1053\/euhj.2002.3160"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Valente S, Lazzeri C, Salvadori C, Chiostri M, Giglioli C, Poli S, et al. Effectiveness and safety of routine primary angioplasty in patients aged ≥85 years with acute myocardial infarction. Circ J 2008; 72: 67-70.","DOI":"10.1253\/circj.72.67"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction: Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999; 341: 1949-1956.","DOI":"10.1056\/NEJM199912233412601"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1253\/circj.71.1360"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(96)02701-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nakagawa Y, Mitsudo K, Kimura T, Morimoto T, Muramatsu T, Shiode N, et al: Incidence and predictor of late stent thrombosis after implantation of sirolimus-eluting stent: From two-year clinical follow-up of the j-Cypher Registry. Circulation 2007; 116(Suppl): II_753-a.","DOI":"10.1161\/circ.116.suppl_16.II_753-a"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60314-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, et al. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet 2007; 370: 937-948.","DOI":"10.1016\/S0140-6736(07)61444-5"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Iwata Y, Kobayashi Y, Fukushima K, Kitahara H, Asano T, Ishio N, et al. Incidence of premature discontinuation of antiplatelet therapy after sirolimus-eluting stent implantation. Circ J 2008; 72: 340-341.","DOI":"10.1253\/circj.72.340"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Wang TY, Chen AY, Roe MT, Alexander KP, Newby LK, Smith SC Jr, et al. Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative. Am J Cardiol 2007; 100: 391-396.","DOI":"10.1016\/j.amjcard.2007.03.035"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Gold HK, Garabedian HD, Dinsmore RE, Guerrero LJ, Cigarroa JE, Palacios IF, et al. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators: Observations in animals and Humans. Circulation 1997; 95: 1755-1759.","DOI":"10.1161\/01.CIR.95.7.1755"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00923-2"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: A statement from the International Committee of Medical Journal Editors. Lancet 2004; 364: 911-912.","DOI":"10.1016\/S0140-6736(04)17034-7"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/73\/1\/73_CJ-08-0560\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T20:52:33Z","timestamp":1632862353000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/73\/1\/73_CJ-08-0560\/_article"}},"subtitle":["Data From Japanese Evaluation of c7E3 Fab for Elective and Primary PCI Organization in Randomized Trial (JEPPORT)"],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-08-0560","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}